Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials

BACKGROUND: Conflicting results on the role of secreted protein acidic and rich in cysteins (SPARC) expression have been reported in resected pancreatic ductal adenocarcinoma (PDAC), and its prognostic and/or predictive role in advanced PDAC (aPDAC) has not been extensively investigated yet. This st...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Br J Cancer
Auteurs principaux: Ormanns, Steffen, Haas, Michael, Baechmann, Sibylle, Altendorf-Hofmann, Annelore, Remold, Anna, Quietzsch, Detlef, Clemens, Michael R, Bentz, Martin, Geissler, Michael, Lambertz, Helmut, Kruger, Stephan, Kirchner, Thomas, Heinemann, Volker, Boeck, Stefan
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2016
Sujets:
Translational Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5155356/
https://ncbi.nlm.nih.gov/pubmed/27802454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.355
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires